Physician profile
Krisann E Schulz
NPI 1528363900
$1,708.95
in general payments reported to CMS, 2019-2025
20 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $381 · 2022: $310 · 2023: $697 · 2024: $189 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,018.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $409.33 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Exeltis, USA INC. | $320.55 | 2023 | Slynd |
| Merck Sharp & Dohme LLC | $241.86 | 2021-2023 | Steglatro, Belsomra, Gardasil 9 |
| Abbvie INC. | $157.57 | 2021-2025 | |
| Pfizer INC. | $122.99 | 2021-2023 | |
| Novo Nordisk INC | $100.57 | 2021-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $68.60 | 2021-2025 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $57.21 | 2021-2022 | |
| Abbott Laboratories | $34.08 | 2021-2022 | |
| Exact Sciences Corporation | $31.86 | 2024 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $23.92 | 2021 | |
| Axsome Therapeutics, INC. | $23.04 | 2023 | Auvelity |
| Inogen, INC. | $18.47 | 2022 | |
| Sanofi Pasteur INC. | $17.23 | 2022 | |
| Astellas Pharma US INC | $15.52 | 2023 | Veozah |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.79 | 2025 | |
| Glaxosmithkline, LLC. | $14.61 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.11 | 2021 | |
| Amgen INC. | $11.75 | 2021 | |
| Genentech USA, INC. | $10.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krisann Schulz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.